jump link

citizen service

WHERE?

You enter your place of residence or the place where you want to contact the administration or use the location sensing.

WHAT?
play_arrow
Enter words here that describe what you are looking for (e.B. cut a tree) or a matter for citizens and companies (e.B. house construction, marriage).
Source: BUS Sachsen-Anhalt (Linie6Plus)

View summaries of risk management plans (RMPs) for authorized medicinal products

Description

The Risk Management Plan (RMP) is a mandatory part of the marketing authorization documents of a medicinal product and is updated throughout the entire life cycle of a medicinal product.

The published RMP Summary is part of the RMP and describes the safety profile of a medicinal product and lists the measures planned for further investigation and monitoring of the risks and for their prevention or minimization.

By publishing the RMP summaries, the Federal Institute for Drugs and Medical Devices (BfArM) informs you as a user, for example as a

  • patients
  • nursing staff
  • Doctors and physicians,
  • pharmacist or as a representative of the
  • representative of the healthcare system.

The RMP summaries are published in German and English on the portal for drug information of the federal and state governments (online platform PharmNet.Bund). On its website, the BfArM publishes a monthly updated list of preparations for which an RMP summary has already been posted on PharmNet.Bund.

The RMP summaries supplement the summaries of the Public Assessment Reports (PAR) on medicinal products, which are also publicly available on PharmNet.Bund, as well as the package leaflets and information for healthcare professionals.

There are no prerequisites.

You do not need to submit any documents.

There are no costs.

There is no deadline.

The BfArM publishes the RMP summaries promptly after authorization of the corresponding medicinal products. Priority for publication is given to new authorizations of original preparations. Thereafter, RMP summaries for generics (copycat products) are also considered for publication.

The publication of the RMPs is not an appealable decision.

Forms available: No

Written form required: No

Informal application possible: No

Personal appearance necessary: No

Online services available: Yes

  • Open the online platform PharmNet.Bund.
  • Click on "Drug information system" and then on "Search".
  • Accept the declaration of consent.
  • After entering the active substance or trade name you are looking for, you will be taken to the documents of the RMP summary (German and English) under "Additional documents".

There are no indications or special features.

Federal Ministry of Health (BMG)

Federal Institute for Drugs and Medical Devices (BfArM)


Forwarding service: Deep link to the original portal

The text was automatically translated based on the German content.

Start your request directly online:

Paul-Ehrlich-Institut (PEI), Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
Paul-Ehrlich-Straße 51-59
63225 Langen (Hessen)
+49 6103 77-0

Remark: Hotline für Anfragen aus der Öffentlichkeit und medizinischen Fachkreisen
+49 6103 77-1771
+49 6103 77-1234
  • Montag bis Freitag: 9:00 - 17:00 Uhr
Further Authorities
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn, Stadt
Remark: Bonn office
+49 228 99307-0
+49 228 99307-5207